Literature DB >> 12474990

Epileptic seizures, cranial neuralgias and paroxysmal symptoms in remitting and progressive multiple sclerosis.

M Eriksson1, E Ben-Menachem, O Andersen.   

Abstract

The occurrence of a first epileptic seizure, spinal or brainstem paroxysmal symptom and cranial neuralgia during 25 years after onset was studied in a population-based multiple sclerosis (MS) cohort of 255 patients. Epileptic seizures occurred in 20, paroxysmal symptoms in 11 and cranial (trigeminal, intermedius, retroauricular or occipital) neuralgia in 11 patients. The yearly incidence of epileptic seizures in MS was estimated to be 349(+/-153)/100,000, approximately seven times higher than in the general population. The yearly incidence of a first paroxysmal symptom in the present material was calculated to be 190 cases in 100,000 MS patients, and the yearly incidence of cranial neuralgia was 189 cases in 100,000 MS patients. The epileptic seizures were more frequent during the progressive course than in the relapsing-remitting (RR) course. The frequencies of paroxysmal symptoms and cranial neuralgia did not differ between these two disease courses. A coincidence of epileptic seizures and a decline in cognitive functioning not seen among patients with paroxysmal symptoms was found The relatively late occurrence of epileptic seizures indicates that the frequency of epileptogenesis, known to involve neuronal damage, increases in the later stages of MS.

Entities:  

Mesh:

Year:  2002        PMID: 12474990     DOI: 10.1191/1352458502ms812oa

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  12 in total

1.  Paroxysmal symptoms in multiple sclerosis masquerading as transient ischaemic attacks.

Authors:  T J V Yates; F Crawley
Journal:  BMJ Case Rep       Date:  2010-07-23

2.  Symptomatic paroxysmal dysarthria-ataxia in demyelinating diseases.

Authors:  Christophe Marcel; Mathieu Anheim; Constance Flamand-Rouvière; Françoise Heran; Pascal Masnou; Clotilde Boulay; Ivan Mari; Christine Tranchant; Emmanuel Roze
Journal:  J Neurol       Date:  2010-03-30       Impact factor: 4.849

Review 3.  Seizures in patients with multiple sclerosis: epidemiology, pathophysiology and management.

Authors:  Brendan J Kelley; Moses Rodriguez
Journal:  CNS Drugs       Date:  2009-10       Impact factor: 5.749

4.  Lesion correlates of secondary paroxysmal dyskinesia in multiple sclerosis.

Authors:  Kilian Fröhlich; Klemens Winder; Ralf A Linker; Konstantin Huhn; Tobias Engelhorn; Arnd Dörfler; De-Hyung Lee; Stefan Schwab; Frank Seifert
Journal:  J Neurol       Date:  2018-07-31       Impact factor: 4.849

Review 5.  Prevalence of Seizure/Epilepsy in Patients with Multiple Sclerosis: A Systematic Review and Meta-Analysis.

Authors:  Omid Mirmosayyeb; Vahid Shaygannejad; Nasim Nehzat; Aida Mohammadi; Mahsa Ghajarzadeh
Journal:  Int J Prev Med       Date:  2021-02-24

Review 6.  A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosis.

Authors:  Ruth Ann Marrie; Nadia Reider; Jeffrey Cohen; Maria Trojano; Per Soelberg Sorensen; Gary Cutter; Stephen Reingold; Olaf Stuve
Journal:  Mult Scler       Date:  2014-12-22       Impact factor: 6.312

Review 7.  A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview.

Authors:  Ruth Ann Marrie; Jeffrey Cohen; Olaf Stuve; Maria Trojano; Per Soelberg Sørensen; Stephen Reingold; Gary Cutter; Nadia Reider
Journal:  Mult Scler       Date:  2015-01-26       Impact factor: 6.312

8.  Safety profile of dalfampridine extended release in multiple sclerosis: 5-year postmarketing experience in the United States.

Authors:  Michele Jara; Thomas Aquilina; Peter Aupperle; Adrian L Rabinowicz
Journal:  Drug Healthc Patient Saf       Date:  2015-12-15

9.  Dalfampridine extended release tablets: 1 year of postmarketing safety experience in the US.

Authors:  Michele Jara; Graham Barker; Herbert R Henney
Journal:  Neuropsychiatr Dis Treat       Date:  2013-03-10       Impact factor: 2.570

10.  Seizure in Iranian patients with multiple sclerosis.

Authors:  Mohammad Zare; Rasul Norouzi; Vahid Shayegannejad; Fereshteh Ashtari; Majid Ghasemi; Hemaseh Tavahen; Ali Masaeli
Journal:  J Res Med Sci       Date:  2013-07       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.